Evidence map›Paper›PMID 40481577›Full record

ArticleJournal of medical case reports2025

Undifferentiated pleomorphic sarcoma invading thoracic aorta treated by thoracic endovascular aortic repair: a case report.

Haiyang Li, Qihua Gong, Wei Wei

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Aortic malignancy masquerading as infrarenal aortitis: A diagnostic challenge.Journal of vascular surgery cases and innovative techniques · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haiyang LiCardiothoracic Surgery Department, Guiqian International General Hospital, Guizhou, Guiyang, 550000, People's Republic of China. 15504506865@163.com.
Qihua GongCardiothoracic Surgery Department, Guiqian International General Hospital, Guizhou, Guiyang, 550000, People's Republic of China.
Wei WeiCardiothoracic Surgery Department, Guiqian International General Hospital, Guizhou, Guiyang, 550000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUndifferentiated pleomorphic sarcoma arising from the posterior mediastinum and infiltrating the thoracic aorta is exceptionally rare, with few cases reported in scientific literature. CASE PRESENTATION: A 48-year-old Han Chinese man was admitted with persistent chest pain for 2 months; he had not received a diagnosis or treatment plan from the previous hospital. Firstly, thoracic endovascular aortic repair surgery was performed to safeguard the integrity of the thoracic aorta, followed by a biopsy to confirm undifferentiated pleomorphic sarcoma. A chemotherapy plan was then established on the basis of the latest pathological results.

conclusionUndifferentiated pleomorphic sarcoma is highly malignant, complicating diagnosis and treatment and often resulting in a poor prognosis. Invasion of the posterior mediastinum and aorta is exceptionally rare. An early thoracic endovascular aortic repair intervention to protect the aorta and cut tumor blood supply, followed by needle biopsy for diagnosis, offers an innovative approach that can guide clinical practice.

Indexed as

Aorta, ThoracicEndovascular ProceduresMediastinal NeoplasmsSarcomaVascular NeoplasmsChest PainEndovascular Aneurysm RepairHumansMaleMiddle AgedNeoplasm InvasivenessTomography, X-Ray ComputedTreatment OutcomeCase reportThoracic aortaThoracic endovascular aortic repair (TEVAR)Undifferentiated pleomorphic sarcoma (UPS)

Identifiers

PMID40481577
PMCPMC12144755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.